Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
We need your mantras for a new project! Share with us.
We are aware of and actively working on an issue where the first page/opening posts of threads with more than one page are not able to be accessed. We hope to have this resolved soon. Thank you for your patience!

New BCO Content on Recently Approved Immunotherapy Jemperli

moderators
moderators Posts: 10,281
edited January 2023 in Immunotherapy - Before, During, and After

Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available.

Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy.

Learn more about:

Read more.

Categories

Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.